Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching AnalysisTakashi Niizeki, Yasuhito Tanaka, Takayuki Tokunaga et al.|Targeted Oncology|2022Cited by 41
A case of ASPL-TFE3 renal carcinoma twelve years after primary operationKatsunori Takagi, Yukichi Tanaka, Takashi Miura et al.|Medical Entomology and Zoology|2010Cited by 0